Issue Brief
The Relationship Between GLP-1 Use and Trust in Pharmaceutical Companies
September 14, 2026
Featured Experts: Wändi Bruine de Bruin, MSc, PhD, Alison Sexton Ward, PhD, Dana Goldman, PhD
Research
All Research Featured Research
Case Study
Schaeffer Solutions: Addressing the Obesity Crisis
June 25, 2026
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, Alison Sexton Ward, PhD, Erin Trish, PhD, Bryan Tysinger, PhD, PhuongGiang Nguyen, MSPH
Evidence Base
How Medicare’s Evidence Requirements Create Barriers to Equitable Healthcare Access
June 4, 2026
Featured Experts: Alison Sexton Ward, PhD, Olivia Williams, Barry Liden, JD, Alice Chen, PhD, Desi Peneva, MS, Darius Lakdawalla, PhD
News
New Financing Models May Expand Access to Life-Changing Cell and Gene Therapies
March 19, 2026
Featured Experts: Alison Sexton Ward, PhD, Elizabeth Fowler, PhD, JD, Jeremy L. Shane, Darius Lakdawalla, PhD
White Paper
High-Stakes Medicine: Rethinking Policies for the Cost and Value of Cell and Gene Therapies
March 19, 2026
Featured Experts: Alison Sexton Ward, PhD, Elizabeth Fowler, PhD, JD, Jeremy L. Shane, Darius Lakdawalla, PhD
Perspective
The Case for Expanding Access to Weight-Loss Medications
March 12, 2026
Featured Experts: Alison Sexton Ward, PhD
Evidence Base
A Value-Based Price for Anti-Obesity Medications
July 17, 2025
Featured Experts: Alison Sexton Ward, PhD, Dana Goldman, PhD
Journal Article
Proposal for a Value-Based Agreement to Reimburse Anti-Obesity Medicines in Traditional Medicare
July 11, 2025
Featured Experts: Alison Sexton Ward, PhD, Erin Trish, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD
Perspective
A Missed Chance to Make America Healthier and Richer
April 7, 2025
Featured Experts: Alison Sexton Ward, PhD, Dana Goldman, PhD
White Paper
Lifetime Social Returns From Expanding Access to Anti-Obesity Medications
March 27, 2025
Featured Experts: Alison Sexton Ward, PhD, Bryan Tysinger, PhD, PhuongGiang Nguyen, MSPH, Darius Lakdawalla, PhD, Dana Goldman, PhD
Comment Letter
Comments to CMS on Proposed Medicare and Medicaid Coverage of Anti-Obesity Medications
January 27, 2025
Featured Experts: Dana Goldman, PhD, Bryan Tysinger, PhD, Alison Sexton Ward, PhD
Evidence Base
The CBO Report on Medicare and Anti-Obesity Medications Should Not Be the Final Word
October 10, 2024
Featured Experts: Alison Sexton Ward, PhD
Perspective
Medicare Coverage of Weight Loss Drugs Could Save the U.S. Billions of Dollars
April 3, 2024
Featured Experts: Dana Goldman, PhD, Alison Sexton Ward, PhD
Evidence Base
Can a Free Virtual Outreach Series Increase Alzheimer’s Disease Awareness?
December 15, 2023
Featured Experts: Alison Sexton Ward, PhD, Desi Peneva, MS
Comment Letter
Comments in Response to a CBO Call for New Research on Obesity
November 2, 2023
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, Karen Van Nuys, PhD, Alison Sexton Ward, PhD, Bryan Tysinger, PhD, Barry Liden, JD
Comment Letter
Comments to CMS on Proposed Guidance for Coverage with Evidence Development
August 25, 2023
Featured Experts: Alice Chen, PhD, Joseph Grogan, JD, Mireille Jacobson, PhD, Geoffrey Joyce, PhD, Darius Lakdawalla, PhD, Barry Liden, JD, Eugene Lin, MD, MS, Karen Van Nuys, PhD, William Padula, PhD, Alison Sexton Ward, PhD, Julie Zissimopoulos, PhD
White Paper
Benefits of Medicare Coverage for Weight Loss Drugs
April 18, 2023
Featured Experts: Alison Sexton Ward, PhD, Bryan Tysinger, PhD, PhuongGiang Nguyen, MSPH, Dana Goldman, PhD, Darius Lakdawalla, PhD
White Paper
Reducing Racial Disparities in Early Cancer Diagnosis With Blood-Based Tests
July 12, 2021
Featured Experts: Alison Sexton Ward, PhD, Karen Van Nuys, PhD, Darius Lakdawalla, PhD
